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PHeart Rhythm Disorders
A Novel SCN5A Gain-of-Function Mutation
M1875T Associated With Familial Atrial Fibrillation
Takeru Makiyama, MD, PHD,* Masaharu Akao, MD, PHD,* Satoshi Shizuta, MD,*
Takahiro Doi, MD,* Kei Nishiyama, MD,* Yuko Oka, MD,† Seiko Ohno, MD, PHD,*
Yukiko Nishio, MD,* Keiko Tsuji, MS,† Hideki Itoh, MD, PHD,† Takeshi Kimura, MD, PHD,*
Toru Kita, MD, PHD,* Minoru Horie, MD, PHD†
Kyoto and Otsu, Japan
Objectives This study describes a novel heterozygous gain-of-function mutation in the cardiac sodium (Na) channel gene,
SCN5A, identified in a Japanese family with lone atrial fibrillation (AF).
Background SCN5Amutations have been associated with a variety of inherited arrhythmias, but the gain-of-function type modula-
tion in SCN5A is associated with only 1 phenotype, long-QT syndrome type 3 (LQTS3).
Methods We studied a Japanese family with autosomal dominant hereditary AF, multiple members of which showed an onset
of AF or frequent premature atrial contractions at a young age.
Results The 31-year-old proband received radiofrequency catheter ablation, during which time numerous ectopic firings and
increased excitability throughout the right atrium were documented. Mutational analysis identified a novel missense
mutation, M1875T, in SCN5A. Further investigations revealed the familial aggregation of this mutation in all of the
affected individuals. Functional assays of the M1875T Na channels using a whole-cell patch-clamp demonstrated a
distinct gain-of-function type modulation; a pronounced depolarized shift (16.4 mV) in V1/2 of the voltage depen-
dence of steady-state inactivation; and no persistent Na current, which is a defining mechanism of LQTS3. These
biophysical features of the mutant channels are potentially associated with increased atrial excitability and normal QT
interval in all of the affected individuals.
Conclusions We identified a novel SCN5Amutation associated with familial AF. The mutant channels displayed a gain-of-function
type modulation of cardiac Na channels, which is a novel mechanism predisposing to increased atrial excitability
and familial AF. This is a new phenotype resulting from the SCN5A gain-of-function mutations and is distinct from
LQTS3. (J Am Coll Cardiol 2008;52:1326–34) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.07.013f
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ihe cardiac sodium (Na) channel plays a crucial role in
ardiac excitation/contraction via initiating the action po-
ential of the conduction system and working myocytes.
utations in SCN5A—which encodes the -subunit of
oltage-gated cardiac Na channels—have been associated
ith a variety of cardiac arrhythmias. The loss-of-function
utations result in Brugada syndrome (1), idiopathic ven-
ricular fibrillation (2), cardiac conduction disease (3), or
ongenital sick sinus syndrome (4), whereas the gain-of-
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chool of Medicine, Kyoto, Japan; and the †Department of Cardiovascular and
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inistry of Health, Labor and Welfare of Japan.f
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ccepted July 10, 2008.unction type modulation in SCN5A is associated with only
phenotype, long-QT syndrome type 3 (LQTS3) (5).
We reported on the screening for SCN5A mutations in
apanese patients with Brugada syndrome (6) and now
ave extended the cohort to various inherited arrhyth-
ias, given the wide spectrum of clinical phenotypes of
ardiac Na channelopathies. In the present study, in
Japanese family with lone atrial fibrillation (AF),
e identified a novel missense mutation of SCN5A
M1875T). Until recently, only potassium channel mu-
ations have been linked to familial AF (7–10); however,
recent reports have identified SCN5A loss-of-function
utations: D1275N in 2 families with atrial arrhythmias
AF, cardiac conduction disease, or sick sinus syndrome)
lus dilated cardiomyopathy (11,12), and N1986K in a
amily with lone AF (13). Thus, this is the first report to
dentify an SCN5A gain-of-function type mutation in
amilial AF.
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linical evaluation. This study was approved by the Insti-
utional Ethics Committee, and all patients provided informed
onsent. Affected individuals were considered as having AF or
remature atrial contractions (PACs) when documented by
2-lead electrocardiograms (ECGs). Lone AF was defined as
nset of AF at age 65 years without structural heart disease,
ypertension, hyperthyroidism, myocardial infarction, or con-
estive heart failure. Paroxysmal AF was defined as sporadic
F lasting 30 s for 7 days. When sustained beyond 7
ays, AF was considered persistent. Atrial fibrillation re-
ractory to cardioversion or not attempted was classified as
ermanent. In both sinus rhythm and AF, the mean QT
nd RR intervals were measured from 3 and 6 consecutive
eats, respectively.
eoxyribonucleic acid (DNA) isolation and mutation
nalysis. Genomic DNA was isolated from blood lympho-
ytes and screened for candidate genes by denaturing high-
erformance liquid chromatography with a WAVE System
odel 3500 (Transgenomic, Omaha, Nebraska). Abnormal
onformers were amplified by polymerase chain reaction,
Figure 1 Pedigree and Clinical Features
(A) Pedigree of the family. Phenotypic traits are designated within pedigree symbo
atrial fibrillation [AF]) and after (right panel, sinus rhythm) he underwent radiofrequ
(IV-3) and his uncle (III-1). Exercise-induced AF for the proband and atrial tachycardia fornd sequencing was performed
n an ABI PRISM 3100 DNA
equencer (Applied Biosystems,
oster City, California).
ite-directed mutagenesis and
lectrophysiology. To construct
he SCN5A mutant, we adopted
ite-directed mutagenesis per-
ormed via a kit, QuickChange
I XL (Stratagene, La Jolla, Cali-
ornia). The human cell line
EK293 cultured in a 35-mm
ish was transiently transfected with 0.5 g of either
RcCMV-WT or mutant complementary DNA in combina-
ion with 0.5 g of the bicistronic plasmid (pEGFP-IRES-
1) encoding enhanced green fluorescent protein and the
uman 1-subunit (h1). The Na currents were recorded
8 h after transfection with the whole-cell patch-clamp
echnique at 22°C to 23°C as described elsewhere (14).
esults are expressed as mean  SEM, and statistical
ignificance was established with the Student t test. Statis-
ical significance was assumed for p  0.05.
Electrocardiograms (ECGs) obtained from the proband, IV-3, before (left panel,
atheter ablation. (C) At rest and post-exercise ECGs recorded from the proband
Abbreviations
and Acronyms
AF  atrial fibrillation
AT  atrial tachycardia
ECG  electrocardiogram
LQTS3  long-QT syndrome
type 3
PAC  premature atrial
contraction
WT  wild-typels. (B)
ency cthe uncle can be observed. Continued on next page.
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linical features. We studied a Japanese family with auto-
omal dominant hereditary AF that spanned 3 generations
Fig. 1A). The proband (IV-3) (Fig. 1A), a 31-year-old man,
rst experienced repetitive palpitation due to frequent PACs at
ge 18, which later progressed to paroxysmal AF and atrial
achycardia (AT) at age 27 years (pre-ablation) (Fig. 1B).
Six family members, along with the proband, presented
ith either AF or frequent PACs (Fig. 1A). The majority
hared a similar clinical course with the proband—palpitations
ue to PACs start in their teens, which later progress to
aroxysmal and ultimately persistent AF (Table 1). The
roband and his uncle (III-1) showed exercise-induced AT
nd/or AF (Fig. 1C). The proband’s cousin (IV-1) pre-
ented with frequent PACs (Fig. 1D) that have not yet
rogressed to AF. The ECGs of the affected relatives—with
he exception to the proband’s aunt (II-3), who received
Figure 1 Continued
(D) Electrocardiograms recorded from other affected individuals. Arrows indicate P
onstrated AF.
linical Characteristics of Affected Individuals
Table 1 Clinical Characteristics of Affected Individuals
Individual Gender
Age
(yrs) Arrhythmias
Onset
of PAC
(yrs)
Onset
of AF
(yrs)
M
C
I-2 F 90* Unknown NA NA
II-2 F 75* Permanent AF NA NA
II-3 F 75* Paroxysmal AF,
PACs
NA NA
III-1 M 60 Paroxysmal AF,
PACs
NA 48
III-3 M 57 Permanent AF 15 51
IV-1 M 34 PACs 23 —
IV-3 M 31 Persistent AF 18 27
IV-4 F 29 Permanent AF 12 26Age of death; †disopyramide administration.
AF  atrial fibrillation; HR  heart rate; LAD  left atrial dimension; LVEF  left ventricular ejection frisopyramide—did not show any QT prolongation (Fig. 1D,
able 1). Interestingly, the analysis of P wave morphology in
he affected family members revealed that the majority of PAC
oci were localized in the right atrium (Fig. 1D). The affected
ndividuals received various antiarrhythmic agents (Table 1)
ut, in most cases, to no avail. There was neither structural
eart disease nor a history of major ventricular arrhythmias or
udden cardiac death in this family.
At age 27 years, the proband underwent radiofrequency
atheter ablation. Intravenous administration of isoprotere-
ol induced repetitive ATs from multiple origins in the
ight atrium (Fig. 2A). We successfully ablated the major
rigin, located in the lower-right atrial septum (Figs. 2B
nd 2C).
Three years later, the second ablation session was per-
ormed due to a relapse of persistent AF. This time, we
dentified 2 other PAC foci in the right atrium (Fig.
s of premature atrial contractions (PACs) in II-3, III-1, and IV-1. III-3 and IV-4 dem-
HR
(beats/min)
QRS
(ms) QTc
LAD
(mm)
LVEF
(%)
Antiarrhythmic
Agents Used
to Treat AF
NA NA NA NA NA NA
88 74 427 36 79 —
77† 104† 478† 30 75 Disopyramide
70 92 394 32 75 Disopyramide,
cibenzoline,
aprindine
71 82 385 NA NA —
68 82 399 ND ND —
65 81 388 30 63 Pilsicainide,
flecainide
88 87 429 31 61 Pilsicainidewaveutation
arrier
ND
ND
ND
Yes
Yes
Yes
Yes
Yesaction; NA  records not available; ND  not determined; PAC  premature atrial contraction.
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Figure 2 Radiofrequency Catheter Ablation Recordings
The first (A to C) and the second (D and E) ablation sessions on the proband. (A) Repetitive atrial tachycardias (ATs) from multiple origins. Shown are intracardiac recordings from the
coronary sinus (CS), the His bundle (His), and a catheter placed along the posterior septum (PS) in the right atrium. Note that atrial activation sequences in CS during ATs were consis-
tently proximal to distal, suggesting right atrial origins. Asterisks indicate the successfully ablated AT originating from the lower-right atrial septum. (B) Fluoroscopic images of the elec-
trodes in the left anterior oblique (LAO) and right anterior oblique (RAO) views. Position of the ablation catheter (ABL; indicated by arrows); successful ablation site of the AT. (C) Three-
dimensional electroanatomic map of the AT in the right posterior oblique view. The AT focus in the lower-right atrial septum was successfully ablated in the first session. (D) Noncontact
mapping of PACs in the right lateral view. Two PAC foci in the middle of the crista terminalis (upper panel) and the high posterolateral wall (lower panel) ablated successfully in the sec-
ond session are shown. (E) Numerous electrical firings (‘) from the contact site during radiofrequency energy delivery in generating tricuspid valve isthmus block. Continuous pacing was
performed from proximal CS. Stim  stimulator; TV  tricuspid valve annulus; other abbreviations as in Figure 1.
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uent procedure to generate a cavotricuspid isthmus block,
e noticed that energy delivery from the catheter induced
umerous electrical firings from the contact sites (Fig. 2E).
fter the second ablation session, he maintained a sinus
hythm under medication, yet even after which he experi-
nced occasional episodes of paroxysmal AF. Interestingly,
fter each attempt of cardioversion, ATs that lasted for
everal seconds were observed immediately after the shock
as delivered and before sinus rhythm conversion (data not
hown). All of these features strongly suggest the proband’s
ncreased vulnerability to atrial arrhythmias.
enetic analysis. We identified a novel missense muta-
ion, c.5624TC, p.M1875T, in the SCN5A gene in the
roband. Figure 3 shows the denaturing high-performance
iquid chromatography and sequence results (Figs. 3A and
B) and an illustration showing the position of the identi-
ed mutation (Fig. 3C). The amino acid at codon 1875
methionine) is highly conserved among different Na
hannel isoforms and species (Fig. 3D). Furthermore,
his mutation was absent in 210 Japanese control indi-
iduals (420 chromosomes). We failed to identify muta-
ions in any other potential candidate genes of familial
F (KCNQ1, KCNH2, KCNE1, KCNE2, KCNE3,
CNJ2, and KCNA5). Further analysis of the family
M187
exon 28
time (min) 80
ab
so
rb
an
ce
 (
m
V
)
6
NH2
DI DII DIII D
Proband
Control
A B
C
Figure 3 Genetic Analysis
(A) The denaturing high-performance liquid chromatography elution profiles for an
cleic acid sequencing electropherograms demonstrate heterozygosity for a SCN5A
nel. The location of the detected mutation is shown. (D) Amino acid sequence alig
SCN1A, human brain type I; SCN2A, human brain type II; SCN3A, human brain typ
cardiac isoforms of Na channels.embers revealed that the M1875T mutation in SCN5A cerfectly matched their clinical phenotypes (Figs. 1A and
D, Table 1).
unctional analysis of M1875T-SCN5A. We performed
iophysical assays for the novel SCN5A mutation with a
eterologous expression system in HEK293 cells. Figure 4A
llustrates representative whole-cell current traces from cells
xpressing wild-type (WT) and M1875T Na channels in
he presence of the coexpressed Na channel  subunit.
Notably, M1875T channels showed an apparently slower
nactivation compared with WT. The time constants for
oth fast and slow inactivation across a wide range of test
otentials were significantly larger with M1875T in com-
arison with WT (Fig. 4B), indicating impaired inactiva-
ion. Figure 4C shows the peak current-voltage relation for
T and M1875T channels. The maximum current density
f WT was observed at 20 mV but shifted to 30 mV for
1875T. In addition, the peak current density of M1875T
as significantly larger than WT (WT, 326.2  28.2
A/pF, n  23; M1875T, 484.6  49.6 pA/pF, n  31,
 0.01) (Fig. 4D). As in WT, M1875T channels showed
o persistent inward Na currents at the end of a 200-ms
epolarization (Fig. 4E), which is one of the defining
echanisms of QT interval prolongation in patients with
QTS3. The subtracted amplitude at the end of the 200-ms
epolarization was 0.046  0.009% (n  5) of the peak
ATG
  C
TG
ontrol Proband
COOH
M1875D
SCN5A D A L K I QME E K F MA A
SCN1A - - - R - - - - - R - - - S
SCN2A - - - R - - - - - R - - - S
SCN3A - - - R - - - - D R - - - S
SCN4A - - - - Q T - - - - - - - -
mouse - - - - - - - - - - - - - -
rat - - - - - - - - - - - - - -
dog - - - - - - - - - - - - - -
cow - - - - - - - - - - - - - -
chick - - - - - - - - - - - - - -
fly - - - - - - - - - - - - - -
mutation, M1875T, detected in the affected family members. (B) Deoxyribonu-
ion. (C) Topology of the -subunit of voltage-gated cardiac sodium (Na) chan-
ts of SCN5A with related Na channels. The SCN5A indicates human heart;
CN4A, human skeletal muscle. The sequences of other species represent the5T
A
C
IV
SCN5A
mutat
nmen
e III; Surrent for WT and 0.048  0.038% (n  7) for M1875T.
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tate inactivation curves for WT and M1875T channels.
umerical data pertaining to the biophysical properties
herein are summarized in Table 2. The parameters for the
ctivation gate were similar between WT and M1875T. In
ontrast, the half-maximal potential (V1/2) for the steady-
tate inactivation of M1875T showed a marked positive
hift (16.4 mV) compared with that of WT (WT, V1/2 
78.08  0.94 mV, n  22; M1875T, V1/2  61.68 
Figure 4 Macroscopic Na Currents of M1875T Channels
(A) Representative whole-cell current traces of wild-type (WT) and M1875T sodium
inset). (B) Voltage dependence of inactivation time constants. The time course of
exp(t/s). Lower and upper bundles of symbols indicate fast (f) and slow (s
(*p  0.05, **p  0.01). (C) Average current-voltage relationship for WT and M1
current density. Asterisks indicate the voltages at which the current density was s
M1875T channels. The peak current density was significantly larger in M1875T (W
pA/pF, n  31, p  0.05). (E) Representative Na current traces recorded in the
rents were calculated by digital subtraction. M1875T channels showed no persiste.76 mV, n  33, p  0.01). The slope factor (k) for i1875T was significantly larger than that of WT (WT,
 7.13  0.12, n  22; M1875T, k  6.07  0.16,
 33, p  0.01). The pronounced depolarizing shift of
he inactivation gate is likely to increase Na channel
vailability during excitation.
We also investigated the other kinetic properties of Na
hannels: recovery from inactivation, onset of slow inacti-
ation, and closed-state inactivation. Parameters of recovery
rom inactivation and onset of slow inactivation were
channels. Cells were transfected with human 1-subunit (protocol shown as an
ation was fit with a 2 exponential equation: I/Imax  Af  exp(t/f)  As 
constant values, respectively. Statistically significant differences are indicated
hannels. The current is normalized to cell capacitance to give a measure of Na
ally different (*p  0.05). (D) Average peak Na current density of WT and
20 mV, 326.2  28.2 pA/pF, n  23; M1875T at 30 mV, 484.6  49.6
ce or presence of 30 mol/l tetrodotoxin. Tetrodotoxin-sensitive persistent cur-
ard Na currents.(Na)
inactiv
) time
875T c
tatistic
T at 
absen
nt inwdentical between WT and M1875T (Figs. 5B and 5C,
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SCN5A Mutation Associated With Familial AF October 14, 2008:1326–34able 2). With regard to closed-state inactivation, the
xtent was significantly less (WT, A  0.13  0.03 ms,
 9; M1875T, A  0.05  0.02 ms, n  9, p  0.05),
nd the time constant was larger in the M1875T channels
hen compared with WT (WT,   97.1  7.8 ms, n  9;
1875T,  212.7 22.3 ms, n 9, p 0.01) (Fig. 5D,
able 2). These data suggest that the number of inactivated
1875T channels is reduced near the resting potential.
Collectively, the M1875T mutation exhibited a gain-of-
unction type modulation in the cardiac Na channels
ithout persistent inward Na currents: increased peak
a channel density; prolonged time constants of both fast
nd slow inactivation; a large depolarizing shift in V1/2 of
he steady-state inactivation; and a lesser extent and a larger
ime constant with regard to closed-state inactivation. In
hort, the M1875T mutation clearly demonstrates charac-
eristics that make it distinct from the LQTS3-type gain-
f-function modulation.
iscussion
n the present study, we identified a novel gain-of-function
CN5A mutation that causes a familial form of AF. The
linical course of AF development materialized in a similar
ashion among all affected family members (i.e., palpitations
ue to frequent PACs and ATs in their teens, followed by
aroxysmal and then persistent AF). During the clinical
lectrophysiological study in the proband, we recognized
ultifocal activity sites and increased excitability in the
ight atrium. These distinguishing features are presum-
bly associated with the unique biophysical properties of
iophysical Properties of WT and M1875T Channels
Table 2 Biophysical Properties of WT and M1875T Channels
WT M1875T
Activation (mV) (n  23) (n  37)
V1/2 43.61 0.79 44.09 0.72
k 6.53 0.16 5.98 0.18
Steady-state inactivation (mV) (n  22) (n  33)
V1/2 78.08 0.94 61.68 0.76†
k 7.13 0.12 6.07 0.16†
Recovery from inactivation (n  16) (n  25)
Af 0.84 0.01 0.84 0.01
As 0.15 0.01 0.15 0.01
f (ms) 8.95 0.95 8.32 0.83
s (ms) 338.6 30.4 271.6 31.6
Onset of slow inactivation (n  15) (n  16)
A 0.12 0.01 0.12 0.01
 (ms) 773.9 90.0 647.2 70.6
Closed-state inactivation (n  9) (n  9)
A 0.13 0.03 0.05 0.02*
 (ms) 97.1 7.8 212.7 22.3†
ata are mean SEM. Parameters were obtained from fitting individual experiments illustrated in
igure 4. *p  0.05; †p  0.01 versus wild-type (WT).
A and  fractional amplitude and time constant, respectively; n number of tested cells; V1/2
nd k  midpoint potential and slope factor, respectively.he mutant Na channels. It should be noted, however, lhat the size of the pedigree analyzed in this study is
imited.
CN5A mutations and familial AF. Mutations in SCN5A
ave been reported to cause a wide variety of cardiac
rrhythmias. The gain-of-function mutations result in
QTS3 (5), whereas the loss-of-function mutations result
n various phenotypes: 1) Brugada syndrome; 2) idiopathic
entricular fibrillation; 3) cardiac conduction disease; and
) congenital sick sinus syndrome. We previously reported
hat SCN5A-linked Brugada syndrome is a high-risk
roup of bradyarrhythmias, linked predominantly to sick
inus syndrome (6). Although AF is a common compli-
ation of Brugada syndrome (10% to 30%) (6,15), there is
scarcity of reports on SCN5A-positive Brugada syn-
rome and AF.
Atrial fibrillation is the most common form of cardiac
rrhythmia, characterized by rapid irregular activation of the
trium, and a common cause of morbidity and mortality. Atrial
brillation occurs predominantly in elderly persons and is
requently associated with underlying cardiac diseases. In 15%
o 30% of patients, however, an etiology is absent (i.e., lone
F) (16,17). Although AF has been regarded a sporadic and
cquired disease, the familial aggregation of AF has been
hown to be more frequent than previously recognized
18,19). Chen et al. (7) found the first gene mutation
esponsible for familial AF in KCNQ1, which encodes the
-subunit of slow delayed rectifier potassium (K) chan-
els. Since then, 3 additional genes—all of which encode
ardiac K channels—responsible for familial AF have been
dentified: KCNE2 (8), KCNJ2 (9), and KCNA5 (10).
ecently, loss-of-function SCN5A mutations (D1275N)
ere reported to be associated with 2 families who have
trial arrhythmias (AF, cardiac conduction disease, and sick
inus syndrome) with dilated cardiomyopathy (11,12). More
ecently, an SCN5A mutation (N1986K) was identified in a
amily with lone AF (13). Functional assays on the N1986K
hannels revealed a hyperpolarized shift of steady-state
nactivation, indicating a loss-of-function type modulation.
ne of the affected members underwent pacemaker implan-
ation due to sick sinus syndrome, suggesting the underlying
onduction disturbance resulting from the Na channel
oss-of-function. In addition, a common polymorphism
H558R) in SCN5A, present in 20% of the population
20), reduces Na current density (21). The screening for
he polymorphism in 157 patients with lone AF revealed
hat the R558 allele was more common in patients with
one AF than in the control subjects and as such was
onsidered to be a risk factor for lone AF (22). However,
one of the M1875T-positive individuals carried the
558 allele.
These reports implicate a potential relationship be-
ween decreased Na currents and AF; however, to date,
n SCN5A gain-of-function mutation has never been
inked to AF.
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October 14, 2008:1326–34 SCN5A Mutation Associated With Familial AFnique gain-of-function properties of M1875T Na
hannels. To date, SCN5A gain-of-function mutations
ave been reportedly linked to only 1 phenotype, LQTS3.
ersistent inward Na currents observed in these mutant
hannels are considered to cause QT prolongation. How-
ver, M1875T channels did not display persistent inward
a currents (Fig. 4E). This might explain why all of the
ffected and mutation-positive individuals in our study exhib-
ted normal QT interval, with the exception of 1 individual
ho received disopyramide therapy. The functional properties
f M1875T Na channels were quite distinct from those
f LQTS3. The most prominent change was a 16.4 mV
hift in the steady-state inactivation. This is, to the best
f our knowledge, the greatest depolarization shift in all
f the previously reported SCN5A mutants. Some of the
QTS3 mutants (E1295K, A1330P, A1330T, and
1768V) showed a similar depolarizing shift of the
Figure 5 Gating Properties for M1875T Channels
Detailed parameters are given in Table 2. (A) Voltage dependence of relative sodi
means of the voltage protocols, as shown in the inset. Curves were fit with the Bo
tial for half-maximal inactivation or activation (V1/2) and the slope factor k. Note th
of steady-state inactivation compared with wild-type (WT). (B) Time course of recov
exponential equation: I/Imax  Af  (1  exp[t/f])  As  (1  exp[t/s]), wh
the time constants of fast and slow inactivation components, respectively. (C) On
obtained by a double pulse protocol. Curves were fit with a single exponential equ
Na channels from closed-state to inactivated closed-state without an intervening
of closed-state inactivation was fit with a single exponential equation: I/Imax  y0
time constant larger in M1875T channels in comparison with WT.teady-state inactivation without persistent inward Na eurrents; however, the extent of the depolarizing shift
as much less than M1875T (all were 10 mV). The
1875T channels displayed the increased peak Na
urrent density (Fig. 4D), perhaps due to the large
epolarized shift in steady-state inactivation. Interest-
ngly, the location of the mutation is within a complex
egion that includes Ca2 binding EF-hand like motifs and a
utative binding site for calmodulin (23), and thus the muta-
ion might disrupt inactivation by altered calcium sensitivity.
The potential mechanisms by which the identified gain-
f-function mutation might lead to PAC or AF could be
xplained as the following: first, increased inward Na
urrents might cause repolarization failure or early afterde-
olarizations, thereby inducing triggered activities; and
econd, the increased Na currents might increase the
onduction velocity and facilitate the maintenance of the
brillation wave. However, further studies are needed to
) conductance activation and steady-state inactivation were determined by
n equation, I/Imax  (1  exp[VV1/2]/k)
1 to determine the membrane poten-
875T channels showed a pronounced depolarized shift (16.4 mV) in the V1/2
m inactivation was elicited with a double pulse protocol. Data were fit with a 2
and As are fractions of fast and slow inactivation components, and f and s are
slow inactivation. Time course of entry into the slow inactivation state was
I/Imax  y0  A  exp(t/). (D) Closed-state inactivation. The transfer rate of
g state was measured by a double pulse protocol. Time course for development
exp(t/). The extent of closed-state inactivation was significantly less and theum (Na
ltzman
at M1
ery fro
ere Af
set of
ation:
openin
 A lucidate the underlying mechanisms.
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SCN5A Mutation Associated With Familial AF October 14, 2008:1326–34enotype–phenotype relationship and clinical implica-
ions. Quite impressively, the affected family members
hared a similar clinical course with high penetrance—
requent PACs and ATs first appeared during their teens
nd subsequently progressed to AF (Fig. 1A). Increased
utomaticity and irritability in the atrium was demon-
trated by recurrent atrial arrhythmias that were resistant
o ablation or drug therapy, induced PACs during exer-
ise (Fig. 1C), and numerous ectopic firings and in-
reased excitability throughout the right atrium during
atheter ablation (Fig. 2). Because Na channels encoded
y SCN5A are expressed in both the atrium and ventricle,
t remains unknown why our patients showed only atrial
rrhythmias but not ventricular arrhythmias. The differ-
nt electrophysiological properties between atrial and
entricular cells might be the underlying cause. Resting
embrane potential is more depolarized, and the peak
a current density is larger in atrial cells than in
entricular cells in dogs (24). The critical depolarization
nd current threshold for action potential initiation are
maller in atrial cells than in ventricular cells, indicating
hat atrial cells are more readily excitable than ventricular
ells (25).
onclusions
e identified a novel SCN5A gain-of-function mutation
hat causes a familial form of AF without any under-
ying structural heart diseases, which provides us with new
nsight into the pathogenesis of the commonly occurring
orm of AF.
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